Pharmaceutical Spending Insights
The discussion delves into the staggering $2 trillion healthcare expenditure in the U.S., highlighting that pharmaceuticals account for a significantly smaller portion, potentially around 10%. The conversation explores the implications of making pharmaceutical payments zero while considering the future of innovation. Additionally, it touches on the broader scope of healthcare and education, suggesting that various areas, including mental health and dental care, could benefit from similar scrutiny and reform.In this clip
From this podcast
EconTalk
Robin Hanson on Health
Related Questions